专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2004040454A3 METHOD AND APPARATUS FOR PERFORMING MULTI-PAGE WRITE OPERATIONS IN A NON-VOLATILE MEMORY SYSTEM 审中-公开
标题翻译：用于在非易失性存储器系统中执行多页写操作的方法和设备
公开(公告)号：WO2004040454A3
公开(公告)日：2004-10-28
申请号：PCT/US0328195
申请日：2003-09-10
申请人： SANDISK CORP , CHANG ROBERT C , QAWAMI BAHMAN , SABET-SHARGHI FARSHID , LI PING
发明人： CHANG ROBERT C , QAWAMI BAHMAN , SABET-SHARGHI FARSHID , LI PING
IPC分类号： G06F12/02 , G06F12/06
CPC分类号： G06F12/0607 , G06F12/0246 , G06F12/0292
摘要： Methods and apparatus for facilitating multi-page or multi-block operations within a non-volatile memory system. According to one aspect of the present invention, a method for performing a multi-page command includes obtaining a first page number of a first convention that identifies a first page associated with a non-volatile memory, and mapping the first page number to a second page number of a second convention. Like the first page number, the second page number also identifies the first page. Mapping the first page number to the second page number includes identifying a total number of districts associated with the non-volatile memory and a total number of pages associated with each block of a total number of blocks. Finally, the first page is accessed using the second page number and the multi-page command.
摘要翻译：用于在非易失性存储器系统内促进多页或多块操作的方法和装置。根据本发明的一个方面，一种用于执行多页面命令的方法包括：获得标识与非易失性存储器相关联的第一页面的第一约定的第一页面编号;以及将第一页面编号映射到第二页面编号第二个约定的页码。与第一页码一样，第二页码也标识第一页。将第一页码映射到第二页码包括识别与非易失性存储器相关联的区域的总数以及与块的总数量的每个块相关联的总页数。最后，使用第二页码和多页命令访问第一页。

2. 发明申请

WO03077084A2 IMPLEMENTATION OF STORING SECRET INFORMATION IN DATA STORAGE READER PRODUCTS 审中-公开
标题翻译：数据存储阅读器产品中存储秘密信息的实现
公开(公告)号：WO03077084A2
公开(公告)日：2003-09-18
申请号：PCT/US0304862
申请日：2003-02-20
申请人： SANDISK CORP , CHANG ROBERT C , LI PING , SABET-SHARGHI FARSHID
发明人： CHANG ROBERT C , LI PING , SABET-SHARGHI FARSHID
IPC分类号： G06F21/00 , G06F1/00
CPC分类号： G06F21/79 , G06F21/34 , G06F2221/2107
摘要： Methods and apparatus for enabling protected contents such as device keys to be stored on a reader are disclosed. According to one aspect of the present invention, a method for accessing a memory storage device that includes a memory and is coupled to a host system through an adapter, the memory storage device including a memory includes obtaining a key from the adapter. The key is suitable for encrypting information that is arranged to be stored in the memory, and is also suitable for decrypting the encrypted information. The method also includes processing the information using the key. In one embodiment, the information is stored in the memory, and the obtaining the information that is stored in the memory by processing the information such that the information may be decrypted using the key.
摘要翻译：公开了用于使受保护的内容（诸如设备密钥）能够存储在读取器上的方法和装置。根据本发明的一个方面，一种用于访问包括存储器并且通过适配器耦合到主机系统的存储器存储设备的方法，所述存储器存储设备包括存储器包括从所述适配器获取密钥。密钥适用于加密存储在存储器中的信息，也适用于对加密信息进行解密。该方法还包括使用密钥处理信息。在一个实施例中，信息被存储在存储器中，并且通过处理信息来获得存储在存储器中的信息，使得可以使用密钥对信息进行解密。

3. 发明申请

WO2008092908A2 METHOD, SYSTEM, RELAY STATION AND BASE STATION FOR TRANSMITTING DATA IN MOBILE COMMUNICATION 审中-公开
标题翻译：方法，系统，移动站和基站在移动通信中传输数据
公开(公告)号：WO2008092908A2
公开(公告)日：2008-08-07
申请号：PCT/EP2008051150
申请日：2008-01-30
申请人： NOKIA SIEMENS NETWORKS GMBH , LI HUI , LI PING , WANG XINGLIN , LIU TAO , XUE YI SHENG , YU DAN , ZIRWAS WOLFGANG
发明人： LI HUI , LI PING , WANG XINGLIN , LIU TAO , XUE YI SHENG , YU DAN , ZIRWAS WOLFGANG
IPC分类号： H04W16/26 , H04W16/32 , H04W36/22 , H04W48/12 , H04W72/04 , H04W72/08 , H04W74/08 , H04W84/04 , H04W88/08
CPC分类号： H04B7/2606 , H04B7/15557 , H04W16/26 , H04W24/02 , H04W72/0406 , H04W72/085 , H04W84/047
摘要： The present invention provides a data transmission method in mobile communication for a cell having one base station and more than one relay station, the method comprises switching the relay stations between at least two operating modes of signaling transmission under the control of the base station. The present invention also provides a system for transmitting data in mobile communication in a cell having one base station and more than one relay station, wherein when transmitting an uplink signaling or a downlink signaling, the relay stations switch between at least two operating modes under the control of the base station. The present invention also provides a relay station and a base station. By using the method, network, relay station, and base station of the present invention, the data transmission in multiple modes can be achieved, so as to achieve a flexible relay scheme.
摘要翻译：本发明提供了一种用于具有一个基站和多于一个中继站的小区的移动通信中的数据传输方法，该方法包括在基站的控制下在至少两个信令传输的操作模式之间切换中继站。本发明还提供了一种用于在具有一个基站和多于一个中继站的小区中发送移动通信中的数据的系统，其中当发送上行链路信令或下行链路信令时，中继站在至少两个操作模式之间切换，控制基站。本发明还提供一种中继站和基站。通过使用本发明的方法，网络，中继站和基站，可以实现多种模式的数据传输，从而实现灵活的中继方案。

4. 发明申请

WO2005055925A3 14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types 审中-公开
标题翻译： 14-3-3ζ过表达作为不良预后因素，是多种癌症类型的治疗靶点
公开(公告)号：WO2005055925A3
公开(公告)日：2006-03-09
申请号：PCT/US2004029859
申请日：2004-09-10
申请人： UNIV TEXAS , YU DILHUA , YAO JUN , NEAL CHRISTOPHER , YANG WENTAO , ZHOU XIAOYAN , POLLOCK RAPHAEL E , HUNG MIEN-CHIE , YANG JUN , LI PING , NGUYEN NINA
发明人： YU DILHUA , YAO JUN , NEAL CHRISTOPHER , YANG WENTAO , ZHOU XIAOYAN , POLLOCK RAPHAEL E , HUNG MIEN-CHIE , YANG JUN , LI PING , NGUYEN NINA
IPC分类号： A61K20060101 , A61K48/00 , C12Q1/68 , G01N33/574 , A01N61/00 , A61K43/04 , A61K49/00 , C12Q1/00 , C12Q33/53 , G01N33/48
CPC分类号： G01N33/574 , C12Q1/6886 , C12Q2600/118 , C12Q2600/136 , C12Q2600/178
摘要： Methods of determining prognosis in a subject with a hyperproliferative disease, including determining expression and/or function of 14-3-3 zeta in the subject, are disclosed. Also disclosed are methods of making a pharmaceutical agent that modulates apoptosis, including the steps of obtaining one or more candidate, testing the one or more candidate substances to determine their ability to modulate the expression and/or function of 14-3-3 zeta, selecting a candidate substance determined to modulate the expression and/or function of 14-3-3 zeta, and making a pharmaceutical composition that includes the selected candidate substance. In addition, methods of treating a subject with a hyperproliferative disease, including making a pharmaceutical agent by the methods set forth herein, and administering the pharmaceutical agent to a subject, are disclosed. The hyperproliferative disease can be cancer, such as breast cancer.

5. 发明申请

WO2005055925A8 14-3-3 ZETA OVER-EXPRESSION AS A POOR PROGNOSIS FACTOR, AND A THERAPEUTIC TARGET IN MULTIPLE CANCER TYPES 审中-公开
标题翻译： 14-3-3 ZETA超表达作为不良预后因素，以及多种癌症类型的治疗目标
公开(公告)号：WO2005055925A8
公开(公告)日：2005-09-15
申请号：PCT/US2004029859
申请日：2004-09-10
申请人： UNIV TEXAS , YU DIHUA , YAO JUN , NEAL CHRISTOPHER , YANG WENTAO , ZHOU XIAOYAN , POLLOCK RAPHAEL E , HUNG MIEN-CHIE , YANG JUN , LI PING , NGUYEN NINA
发明人： YU DIHUA , YAO JUN , NEAL CHRISTOPHER , YANG WENTAO , ZHOU XIAOYAN , POLLOCK RAPHAEL E , HUNG MIEN-CHIE , YANG JUN , LI PING , NGUYEN NINA
IPC分类号： A61K20060101 , A61K48/00 , C12Q1/68 , G01N33/574 , A01N61/00 , A61K49/00 , C12Q1/00 , G01N33/48 , A61K43/04 , C12Q33/53
CPC分类号： G01N33/574 , C12Q1/6886 , C12Q2600/118 , C12Q2600/136 , C12Q2600/178
摘要： Methods of determining prognosis in a subject with a hyperproliferative disease, including determining expression and/or function of 14-3-3 zeta in the subject, are disclosed. Also disclosed are methods of making a pharmaceutical agent that modulates apoptosis, including the steps of obtaining one or more candidate, testing the one or more candidate substances to determine their ability to modulate the expression and/or function of 14-3-3 zeta, selecting a candidate substance determined to modulate the expression and/or function of 14-3-3 zeta, and making a pharmaceutical composition that includes the selected candidate substance. In addition, methods of treating a subject with a hyperproliferative disease, including making a pharmaceutical agent by the methods set forth herein, and administering the pharmaceutical agent to a subject, are disclosed. The hyperproliferative disease can be cancer, such as breast cancer.
摘要翻译：公开了确定患有过度增生性疾病的受试者的预后的方法，包括确定受试者中14-3-3ζ的表达和/或功能。还公开了制备调节凋亡的药剂的方法，包括获得一种或多种候选物的步骤，测试一种或多种候选物质以确定其调节14-3-3ζ的表达和/或功能的能力，选择确定调节14-3-3ζ的表达和/或功能的候选物质，并制备包含所选候选物质的药物组合物。此外，公开了通过本发明所述的方法制备药剂并且将药剂施用于受试者的治疗患有过度增殖性疾病的受试者的方法。过度增生性疾病可以是癌症，例如乳腺癌。

6. 发明申请

WO2012158423A3 APPARATUS AND METHODS FOR BIASING POWER AMPLIFIERS 审中-公开
标题翻译：放大功率放大器的设备和方法
公开(公告)号：WO2012158423A3
公开(公告)日：2013-03-21
申请号：PCT/US2012037065
申请日：2012-05-09
申请人： SKYWORKS SOLUTIONS INC , LI PING , DICARLO PAUL T
发明人： LI PING , DICARLO PAUL T
IPC分类号： H03F1/30 , H03F3/24
CPC分类号： H03F3/21 , H03F1/0205 , H03F3/19 , H03F3/195 , H03F3/211 , H03F3/213 , H03F3/24 , H03F2200/129 , H03F2200/18 , H03F2200/336 , H03F2200/387 , H03F2200/451 , H03G3/007 , H03G3/3042 , H04B1/3827
摘要： Apparatus and methods for biasing a power amplifier are disclosed. In one embodiment, a method of biasing a power amplifier includes shaping an enable signal using a time-dependent signal generator to generate a control current, amplifying the control current using a current amplifier to generate a correction current, and generating a bias current for a power amplifier using a primary biasing circuit. The primary biasing circuit is configured to use the correction current to correct for a variation in gain of the power amplifier when the power amplifier is enabled.
摘要翻译：公开了用于偏置功率放大器的装置和方法。在一个实施例中，偏置功率放大器的方法包括使用时间相关的信号发生器对使能信号进行整形以产生控制电流，使用电流放大器放大控制电流以产生校正电流，并产生用于功率放大器使用主偏置电路。主要偏置电路被配置为当功率放大器被使能时，使用校正电流来校正功率放大器的增益的变化。

7. 发明申请

WO2005002370A3 CIGARETTE WRAPPER WITH PRINTED CATALYST 审中-公开
标题翻译：香烟包装与印刷催化剂
公开(公告)号：WO2005002370A3
公开(公告)日：2005-03-31
申请号：PCT/US2004018854
申请日：2004-06-14
申请人： PHILIP MORRIS USA INC , LI PING , GEDEVANISHVILI SHALVA , RASOULI FIROOZ , ZHANG WEIJUN , GARG RAJESH K , ALONSO HECTOR
发明人： LI PING , GEDEVANISHVILI SHALVA , RASOULI FIROOZ , ZHANG WEIJUN , GARG RAJESH K , ALONSO HECTOR
IPC分类号： A24B15/28 , A24C5/00 , A24D1/02 , D21H25/00
CPC分类号： A24D1/025 , A24B15/28 , A24B15/282 , A24B15/286 , A24B15/287 , A24B15/288 , A24C5/005 , A24D1/002 , A24D1/02 , C09D11/03 , D21H19/68 , D21H23/24
摘要： A wrapper for a smoking article includes a web; and a patterned deposit on at least a portion of one surface of the wrapper, wherein the patterned deposit comprises catalyst particles. The patterned deposit can include a nanoparticle catalyst that is capable of catalyzing the conversion of a constituent gas component in the mainstream and/or sidestream smoke of the smoking article. The constituent gas component can be carbon monoxide and/or nitric oxide and the catalyst particles can be iron oxide. Also provided is a smoking article comprising a tobacco rod having a wrapper formed around the tobacco rod, the wrapper including a patterned deposit on at least a portion of one surface of the wrapper. A method of making the wrapper and a method of making a smoking article utilizing the wrapper are also provided.
摘要翻译：吸烟制品的包装物包括网; 以及在包装纸的一个表面的至少一部分上的图案化沉积物，其中图案化沉积物包含催化剂颗粒。图案化的沉积物可以包括能够催化吸烟制品的主流和/或侧流烟雾中的构成气体成分的转化的纳米颗粒催化剂。构成气体组分可以是一氧化碳和/或一氧化氮，催化剂颗粒可以是氧化铁。还提供了一种吸烟制品，其包括具有围绕所述烟草棒形成的包装物的烟草棒，所述包装纸包括在所述包装纸的一个表面的至少一部分上的图案化沉积物。还提供了制造包装纸的方法和利用包装纸制作吸烟制品的方法。

8. 发明申请

WO2012075253A2 PHARMACEUTICAL COMPOSITIONS 审中-公开
标题翻译：药物组合物
公开(公告)号：WO2012075253A2
公开(公告)日：2012-06-07
申请号：PCT/US2011062837
申请日：2011-12-01
申请人： NOVARTIS AG , CAO YU , HACKL WOLFGANG , LI PING , LI SHOUFENG , MIRZA TAHSEEN , ZEHENDER HARTMUT , ZHU JIAHAO
发明人： CAO YU , HACKL WOLFGANG , LI PING , LI SHOUFENG , MIRZA TAHSEEN , ZEHENDER HARTMUT , ZHU JIAHAO
IPC分类号： A61K9/16 , A61P35/00
CPC分类号： C07D471/04 , A61K9/1617 , A61K9/1623 , A61K9/1635 , A61K9/1641 , A61K9/1694 , A61K31/00
摘要： The present invention relates to a pharmaceutical composition for the oral administration of a therapeutic compound of formula (I), which comprises granules that comprise at least therapeutic compound of formula (I) (see below), particularly 2-Methyl-2-[4-(3-methyl-2-oxo-8- quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile or 8-(6-methoxy-pyridin-3-yl)-3-methyl-1-(4-piperazin-1-yl-3-trifluoromethyl-phenyl)-1,3-dihydro-imidazo[4,5-c]quinolin-2-one, or a tautomer thereof, or a pharmaceutically acceptable salt, or a hydrate or solvate thereof; at least one non-ionic surfactant that is Vitamin E-TPGS in an amount ranging from about 15 to about 80% by weight of the composition; and at least one a dissolution enhancing agent selected from polyethylene glycol, polyethylene oxide, and any combination of the foregoing. The present invention also relates to processes for making such pharmaceutical compositions; a kit comprising such pharmaceutical composition and the instructions provide that the pharmaceutical composition may be taken immediately to about thirty minutes after the consumption of food; and related uses and methods of treatment.
摘要翻译：本发明涉及用于口服施用式（I）的治疗性化合物的药物组合物，其包含至少包含式（I）的治疗性化合物（参见下文），尤其是2-甲基-2- [4 - （3-甲基-2-氧代-8-喹啉-3-基-2,3-二氢 - 咪唑并[4,5-c]喹啉-1-基） - 苯基] - 丙腈或8-（6-甲氧基 - 吡啶-3-基）-3-甲基-1-（4-哌嗪-1-基-3-三氟甲基 - 苯基）-1,3-二氢 - 咪唑并[4,5-c]喹啉-2-酮，或其互变异构体，或其药学上可接受的盐或水合物或溶剂化物; 至少一种非离子表面活性剂，其量为组合物重量的约15至约80％的量的维生素E-TPGS; 和至少一种选自聚乙二醇，聚环氧乙烷和前述的任意组合的溶解增强剂。本发明还涉及制造这种药物组合物的方法; 包含此类药物组合物和说明书的试剂盒提供了可以立即在食物消耗后约三十分钟服用药物组合物; 以及相关的用途和治疗方法。

9. 发明申请

WO2009097133A2 TRANSGENIC PLANTS WITH ENHANCED AGRONOMIC TRAITS 审中-公开
标题翻译：具有增强农业条件的转基因植物
公开(公告)号：WO2009097133A2
公开(公告)日：2009-08-06
申请号：PCT/US2009000582
申请日：2009-01-29
申请人： MONSANTO TECHNOLOGY LLC , HAUGE BRIAN R , MADAPPA SAVITHA , LUTFIYYA LINDA L , VENKATESH TYAMAGONDLU V , DHANALAKSHMI R , WU XIAOYUN , ZHAO JIANMIN , VIDYA K R , DEZWAAN TODD , RAVENELLO MONICA P , IANDOLINO ALBERTO , AMBIKA T , MORRELL PETER , RODRIGUEZ MARIE F , CHAR SHOBHA , RAJANI M S , CHOMET PAUL , DENG MOLIAN , SANGEETHA S , NEELAM ANIL , MCDILL BRAD , DAVIS JULIE , EDGERTON MICHAEL , HE STEVE , VIJAYALAKSHMI K , RUFF THOMAS , HEARD JACQUELINE , CHITTOOR JASHREE , ABAD MARK , GOLDMAN BARRY , BELL ERIN , CERNY ERIC , MEISTER ROBERT , PETRACEK MARIE , BRUSTAD KRAIG , PITKIN JOHN , URSIN VIRGINIA , LI PING , GABBERT KAREN
发明人： HAUGE BRIAN R , MADAPPA SAVITHA , LUTFIYYA LINDA L , VENKATESH TYAMAGONDLU V , DHANALAKSHMI R , WU XIAOYUN , ZHAO JIANMIN , VIDYA K R , DEZWAAN TODD , RAVENELLO MONICA P , IANDOLINO ALBERTO , AMBIKA T , MORRELL PETER , RODRIGUEZ MARIE F , CHAR SHOBHA , RAJANI M S , CHOMET PAUL , DENG MOLIAN , SANGEETHA S , NEELAM ANIL , MCDILL BRAD , DAVIS JULIE , EDGERTON MICHAEL , HE STEVE , VIJAYALAKSHMI K , RUFF THOMAS , HEARD JACQUELINE , CHITTOOR JASHREE , ABAD MARK , GOLDMAN BARRY , BELL ERIN , CERNY ERIC , MEISTER ROBERT , PETRACEK MARIE , BRUSTAD KRAIG , PITKIN JOHN , URSIN VIRGINIA , LI PING , GABBERT KAREN
IPC分类号： A01H5/00
CPC分类号： C12N15/8273 , C07K14/415 , C12N15/8247 , C12N15/8251 , C12N15/8261 , C12N15/8271 , C12N15/8274 , C12N15/8275 , C12Q1/6895 , C12Q2600/13 , G01N33/68 , G01N2333/415 , Y02A40/146
摘要： This invention provides transgenic plant cells with recombinant DNA for expression of proteins that are useful for imparting enhanced agronomic trait(s) to transgenic crop plants. This invention also provides transgenic plants and progeny seed comprising the transgenic plant cells where the plants are selected for having an enhanced trait selected from the group of traits consisting of enhanced water use efficiency, enhanced cold tolerance, increased yield, enhanced nitrogen use efficiency, enhanced seed protein and enhanced seed oil. Also disclosed are methods for manufacturing transgenic seed and plants with enhanced traits.
摘要翻译：本发明提供具有用于表达蛋白质的重组DNA的转基因植物细胞，其可用于赋予转基因作物植物增强的农艺性状。本发明还提供包含转基因植物细胞的转基因植物和后代种子，其中植物被选择用于具有增强的性状，所述性状选自由增强的水利用效率，增强的耐寒性，增加的产量，增强的氮利用效率，增强的氮利用效率，种子蛋白和增强种子油。还公开了用于制备具有增强特征的转基因种子和植物的方法。

10. 发明申请

WO2008002905A3 SOLID DOSAGE FORMS OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE AND METHOD OF MAKING THE SAME 审中-公开
标题翻译：瓦尔塔坦，阿莫迪汀和氢氯酸的固体剂型及其制备方法
公开(公告)号：WO2008002905A3
公开(公告)日：2008-12-11
申请号：PCT/US2007072097
申请日：2007-06-26
申请人： NOVARTIS AG , NOVARTIS PHARMA GMBH , CAO YU , JOSHI YATINDRA , LI PING , PUDIPEDDI MADHUSUDHAN , ROYCE ALAN EDWARD , WAGNER ROBERT FRANK , ZHU JIAHAO
发明人： CAO YU , JOSHI YATINDRA , LI PING , PUDIPEDDI MADHUSUDHAN , ROYCE ALAN EDWARD , WAGNER ROBERT FRANK , ZHU JIAHAO
IPC分类号： A61K9/20 , A61K31/41 , A61K31/549 , A61K45/06 , A61P9/04 , A61P9/10
CPC分类号： A61K9/2054 , A61K9/209 , A61K31/41 , A61K31/4422 , A61K31/549 , A61K2300/00
摘要： Monolayer, bilayer and trilayer solid dosage forms of a combination of valsartan, amlodipine and hydrochlorothiazide are made.
摘要翻译：制备缬沙坦，氨氯地平和氢氯噻嗪组合的单层，双层和三层固体剂型。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式